Accessibility of Railway Stations: Dulwich and West Norwood
Debate between Helen Hayes and Valerie Vaz(1 month ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Valerie Vaz (Walsall and Bloxwich) (Lab)
My hon. Friend mentioned stations in her constituency, and I would like to mention Bescot Stadium station in my constituency. Does she agree that if a station is inaccessible, the figures that are quoted for its footfall will be much lower?
Helen Hayes
My hon. Friend is absolutely right to say that the figures cannot account for passengers who cannot access a station, and I welcome her campaign for the station in her constituency. This is a national issue. The high number of stations in Dulwich and West Norwood makes it an acute issue in my constituency, but this is a problem everywhere.
When I have inquired about how best to make the case for stations in my constituency, I am told to make representations to the Government and through the Access for All process. I have done so, but there is no process outside of public pressure and political lobbying prior to Access for All applications being submitted to support local communities with a more strategic approach. We need an approach that enables us to join up community views and aspirations with transport feasibility work to understand how to prioritise in a realistic way which of our stations are most likely to secure funding because of their footfall.
Lobular Breast Cancer
Debate between Helen Hayes and Valerie Vaz(10 months ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Helen Hayes
I thank all hon. Members who have contributed. They have brought their constituents’ stories and their own personal experiences to the debate. We have many issues to work on in this House, but there is a particular responsibility when an issue presents itself in a personal way through a devastating story, whether that is through a constituent, somebody we know or our own personal experience. When we see an opportunity for things to be done, it is imperative for us all to bring that to this place. I am grateful to hon. Members for the spirit in which the debate has been conducted, the high level of consensus and the high level of commitment to see change for patients with lobular cancer.
I am grateful to the Minister for her engagement with the debate. I know she is committed to this area. In closing, I ask that she looks in further detail at two issues. The first is the proportional allocation of the funding available through the NIHR for research into breast cancer. We have heard again and again today that lobular cancer accounts for 15% of all breast cancers, yet currently attracts only a tiny fraction of dedicated research. We know that the improvements we have seen in treatments and outcomes for different types of cancer diagnosis always hinge on the investment put into research to find the cures. There is a disproportionality there that can and must be changed.
The second area I ask the Minister to look at in a little more detail is the advice and guidance given to clinicians in primary care, to make sure that there is a consistent understanding of the symptoms of lobular cancer and its distinctiveness as a disease compared with ductal cancer, and to make sure that every woman presenting to her GP is able to access accurate advice and swift onward referral. It is important across the whole range of women’s health conditions that women are trusted and listened to when they present with symptoms to their GP, and this is an area where I believe primary care can do better, be more consistent and deliver better outcomes as a consequence.
I pay tribute once again to Dr Susan Michaelis and all those who campaign on this issue on the basis of their deeply difficult personal experiences. I give my commitment that for as long as I have a voice in this place, I will continue to work on this issue until we see the changes that are needed.
Valerie Vaz (in the Chair)
I thank everyone who took part in and attended this debate.
Question put and agreed to.
Resolved,
That this House has considered the treatment of lobular breast cancer.